Last update 21 Nov 2024

Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dibcalsor, Dikabelin, Neo Vitacain
+ [5]
Target
COX x Nav1.5 x Nav1.8
Mechanism
COX inhibitors(Cyclooxygenases inhibitors), Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers), Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers)
Therapeutic Areas
Nervous System DiseasesSkin and Musculoskeletal Diseases
Active Indication
PeriarthritisLow Back PainMyalgia+ [2]
Inactive Indication-
Originator Organization
Vitacain Pharmaceutical Co. Ltd.
Active Organization
Shiono Chemical Co. Ltd.Shiono Chemical Co. Ltd.NISSIN Pharmaceutical Co., Ltd.Nichi-Iko Gifu Plant Co., Ltd.
+ [1]
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (06 Aug 1959),
Low Back PainMyalgiaNeuralgia+ [1]
Regulation-
Login to view timeline

Structure

Molecular FormulaC27H36Br2CaClN3NaO5
InChIKeySXSMEDSFMLZVDK-UHFFFAOYSA-L
CAS Registry206115-89-1

Related

100 Clinical Results associated with Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide
Login to view more data
100 Translational Medicine associated with Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide
Login to view more data
100 Patents (Medical) associated with Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide
Login to view more data
1
Literatures (Medical) associated with Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide
Stomatologia
Klinika apoteles mata me te chress tou Neo-Lidocaton.
100 Deals associated with Dibucaine Hydrochloride/Sodium Salicylate/Calcium Bromide
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Periarthritis
JP
NISSIN Pharmaceutical Co., Ltd.
31 Jan 1997
Low Back Pain
JP
Vitacain Pharmaceutical Co. Ltd.
06 Aug 1959
Myalgia
JP
Vitacain Pharmaceutical Co. Ltd.
06 Aug 1959
Neuralgia
JP
Vitacain Pharmaceutical Co. Ltd.
06 Aug 1959
Periarthritis scapulohumeralis
JP
Vitacain Pharmaceutical Co. Ltd.
06 Aug 1959
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free